DOI:
10.1055/s-00000015
European Journal of Pediatric Surgery
LinksClose Window
References
Tonini GP, Boni L, Pession A, Rogers D, Iolascon A, Basso G, Cordero di Montezemolo L, Casale F, Perri P, Mazzocco K, Scaruffi P, Lo Cunsolo C, Marchese N, Milanaccio C, Conte M, Bruzzi P, De Bernardi B.
MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4 s: the Italian experience with 295 children.
J Clin Oncol 1997; 15: 85-93
We do not assume any responsibility for the contents of the web pages of other providers.